US FDA panel backs Bristol transplant drug
Reuters - 9 minutes ago
WASHINGTON, March 1 (Reuters) - Bristol-Myers Squibb Co's (BMY.N) experimental kidney transplant drug belatacept should be approved to give doctors and patients more treatment options, but long ...
http://digg.com/u1OhKK
No comments:
Post a Comment